VPT:CC - Ventripoint Hires Two Strategic Sales Account Managers for US Europe and UK Distribution
(TheNewswire)
Toronto, Ontario – TheNewswire –May 9, 2022 - Ventripoint Diagnostics Ltd.(" Ventripoint " or the " Company "), (TSXV:VPT ) ; ( OTC:VPTDF) is pleased to announce that two new strategicsales account managers have been hired to assist in the expansion ofglobal sales. Each account manager has the required skill set formanaging the sales and distribution of the VMS+ product on a globalscale.
The account manager in charge of the UnitedKingdom/European sales and distribution has over two decades ofexperience in medical device sales. He has managed international salesteams within the cardiac device market, as well as worked extensivelywith multiple distributors. Ventripoint will benefit from theentrepreneurial and start-up mindset of this new hire and is expectingto see an increase in sales with this added support.
The account manager in charge of the United Statessales and distribution also has over two decades of experience inmedical device sales. He has experience working with contracting GroupPurchasing Organizations (GPOs) and Integrated Delivery Networks(IDNs). They also have extensive experience training multiple teams ofclinical sales representatives, along with managing teams of clinicalsale specialists.
Ventripoint has been rapidly growing within the pastyear and has been expanding into new markets. The two sales accountmanagers will be an integral part of Ventripoint’s sales andmarketing efforts towards meeting and surpassing the sales goals ofthe VMS+.
About Ventripoint DiagnosticsLtd.
Ventripoint has become anindustry leader in the application of AI (Artificial Intelligence) toechocardiography. Ventripoint's VMS products are powered by itsproprietary KBR technology, which is the result of a decade ofdevelopment and provides accurate volumetric cardiac measurementsequivalent to MRI. This affordable, gold-standard alternative allowscardiologists greater confidence in the management of their patients.Providing better care to patients serves as a springboard and basicstandard for all of Ventripoint's products that guide our futuredevelopments. In addition, VMS+ is versatile and can be used with allultrasound systems from any vendor supported by regulatory marketapprovals in the U.S., Europe and Canada.
For further information, pleasecontact:
Dr. George Adams
519-803-6937
Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this news release.
Forward Looking Statements
This news release contains forward-looking statementsand forward-looking information within the meaning of applicablesecurities laws. The use of any of the words "expect","anticipate", "continue", "estimate","objective", "ongoing", "may","will", "project", "should","believe", "plans", "intends'' and similarexpressions are intended to identify forward-looking information orstatements. The forward-looking statements and information are basedon certain key expectations and assumptions made by the Company.Although the Company believes that the expectations and assumptions onwhich such forward-looking statements and information are based arereasonable, undue reliance should not be placed on the forward-lookingstatements and information because the Company can give no assurancethat they will prove to be correct.
Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differmaterially from those currently anticipated due to a number of factorsand risks. Factors which could materially affect such forward-lookinginformation are described in the risk factors in the Company's mostrecent annual management's discussion and analysis that is availableon the Company's profile on SEDAR at www.sedar.com. Readers arecautioned that the foregoing list of factors is not exhaustive. Theforward-looking statements included in this news release are expresslyqualified by this cautionary statement. The forward-looking statementsand information contained in this news release are made as of the datehereof and the Company undertakes no obligation to update publicly orrevise any forward-looking statements or information, whether as aresult of new information, future events or otherwise, unless sorequired by applicable securities laws.
Copyright (c) 2022 TheNewswire - All rights reserved.